Close Menu

At the Association for Molecular Pathology's annual meeting in San Jose last week, Harvard Medical School's Jonathan Seidman made a case for the importance of studying rare genetic variants that cause cardiomyopathy. Various genes cause different pathway mutations that lead to cardiomyopathy, Seidman said, and cardiologists can't distinguish between them. While there are several common variants, there are multiple rare variants that can significantly increase a patient's chances of suffering from the disease.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.